Safety, tolerability, pharmacokinetics, and insulinotropic activity of single subcutaneous doses of LY2189265, a long-acting glucagon-like peptide 1 (GLP-1) analog in healthy subjects

Authors
Category Primary study
JournalDiabetes
Year 2009
This article has no abstract
Epistemonikos ID: 4990f6f4dbbb66ac5277735a4e56c3dc3cac1f2f
First added on: Feb 28, 2025